Regenerating warfighter mobility with EB-OC- a next-generation living osteochondral graft to treat combat-acquired osteoarthritis

Active Purchase Order Awarded Last action

Contract number
FA864925P0473
Awardee
Awarding agency
Obligated
$1,249,964

Award facts

Contract value 100% obligated
$1,249,964.00 Current and potential, with all options
Completion date 66% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 105 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Jersey City, NJ 07302, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,249,964

About this award

The Air Force Research Laboratory awarded a purchase order to Epibone, Inc. for $1,249,964 on August 28, 2025, under a Total Small Business set-aside. The order funds development of EB-OC, a next-generation living osteochondral graft to treat combat-acquired osteoarthritis in warfighters. Performance occurs in Jersey City, New Jersey, with completion targeted for June 1, 2027. The contract is firm fixed price.

Quick answers

Who was awarded contract FA864925P0473?

FA864925P0473 was awarded to Epibone, Inc. by Air Force Research Laboratory (Air Force Materiel Command) on August 28, 2025.

How much is contract FA864925P0473 worth?

The government has obligated $1,249,964 on FA864925P0473.

Was contract FA864925P0473 competed?

The extent of competition for FA864925P0473 was full and open competition after exclusion of sources. The government received 105 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award